A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

NCT00391027 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine (Lantus®)
DRUG: Inhaled Human Insulin (Exubera®)

Sponsor

Pfizer